Previous 10 |
Microbot Medical (NASDAQ: MBOT ) has filed a preliminary prospectus for an offering of up to ~6M Units, each consisting of one common share and one warrant to purchase one share of common at an assumed exercise price of $1.66. More news on: Microbot Medical Inc, Healthcare stocks news, S...
Gainers: PRQR +62% . MNKD +33% . SBOT +19% . VCEL +18% . NSU +17% . SYBX +15% . CORV +15% . VRA +15% . MVIS +14% . IGC +13% . More news on: ProQR Therapeutics, MannKind Corporation, Stellar Biotechnologies Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Microbot Medical Inc. Company Name:
MBOT Stock Symbol:
NASDAQ Market:
Microbot Medical Inc. Website:
BRAINTREE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic Surgical System, today announces it has received Institutional Review Board (IRB) approval and signed a clinical trial agreement with Memor...
Baptist Hospital of Miami is the second site to perform clinical procedures as part of the Company’s Pivotal Human Clinical Trial. The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY ® Endovascular R...
The first clinical case was performed at Brigham and Women’s Hospital The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY ® Endovascular Robotic Surgical System BRAINTREE, Mass., July 08, 2024 (G...